Lipocine's market cap is currently $19.41M. The company's EPS TTM is $-0.759; its P/E ratio is ―; Lipocine is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ -2.85M	$ 500.00K	$ 16.14M	$ 0.00	$ 164.99K
Gross Profit	$ -2.85M	$ 500.00K	$ 16.14M	$ 0.00	$ 164.99K
Operating Income	$ -17.93M	$ -12.12M	$ 3.15M	$ -18.00M	$ -12.90M
EBITDA	$ -16.32M	$ -10.72M	$ -430.53K	$ -17.99M	$ -12.65M
Net Income	$ -16.35M	$ -10.76M	$ -634.40K	$ -20.96M	$ -13.01M
Balance Sheet
Cash & Short-Term Investments	$ 22.04M	$ 32.53M	$ 44.62M	$ 19.67M	$ 14.07M
Total Assets	$ 23.00M	$ 37.54M	$ 52.48M	$ 25.35M	$ 19.66M
Total Debt	$ 17.17K	$ 0.00	$ 2.31M	$ 5.59M	$ 7.15M
Net Debt	$ -4.75M	$ -3.15M	$ -639.73K	$ -13.63M	$ -2.58M
Total Liabilities	$ 2.63M	$ 1.91M	$ 6.91M	$ 10.01M	$ 13.37M
Stockholders' Equity	$ 20.37M	$ 35.63M	$ 45.57M	$ 15.34M	$ 6.29M
Cash Flow
Free Cash Flow	$ -11.88M	$ -12.10M	$ -4.42M	$ -15.30M	$ -11.67M
Operating Cash Flow	$ -11.87M	$ -11.97M	$ -4.41M	$ -15.30M	$ -11.67M
Investing Cash Flow	$ 13.08M	$ 14.29M	$ -43.78M	$ 3.89M	$ 3.00M
Financing Cash Flow	$ 404.57K	$ -2.13M	$ 26.92M	$ 20.90M	$ 10.32M

Currency in USD

Lipocine Earnings and Revenue History

Income Statement >

Lipocine Debt to Assets

Balance Sheet >

Lipocine Cash Flow

Cash Flow >

Lipocine Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing